Table 1 Clinically Evaluable Population
Number of patients, n (%) | Tigecycline (N = 138) | Levofloxacin (N = 156) | Total (N = 294) |
|---|---|---|---|
Patients switched to oral therapy | 124 (89.9%) | 137 (87.8%) | 261 (88.8%) |
Patients not switched to oral therapy | 14 (10.1%) | 19 (12.2%) | 33 (11.2%) |
Patients meeting switch criteria as determined by present analysis | 93 (67.4%) | 104 (66.7%) | 197 (67.0%) |
Patients not meeting switch criteria as determined by present analysis | 45 (32.6%) | 52 (33.3%) | 97 (33.0%) |
Patients switched without meeting switch criteria as determined by present analysis | 31 (22.5%) | 33 (21.2%) | 64 (21.8%) |